The Patent Finder

China Pharmaceutical University

22 patents currently held · Updated Nov 20, 2026
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Dec 2034
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 3, 2027
    The maintenance fee for Naphthalenesulfonamide compound, preparation method, and application (US 11,773,057) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.
  • 1 fee due Jul 7, 2027
    The maintenance fee for Pentapeptide associated with integrin receptor alpha vbeta3 (US 10,526,370) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
  • 1 fee due Aug 20, 2027
    The maintenance fee for Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament (US 11,905,230) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof (US 11,970,523) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
  • 1 fee due Nov 5, 2027
    The maintenance fee for Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarction (US 10,639,289) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 22, 2026
  • 1 term has ended since Aug 22, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,085,022Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof
In force
 · USPTO record
In forceUSPTO record
US 10,526,370Pentapeptide associated with integrin receptor alpha vbeta3
In force (reinstated)
 · USPTO record
In force (reinstated)USPTO record
US 10,639,289Application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarction
In force
 · USPTO record
In forceUSPTO record
US 11,905,230Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament
In force
 · USPTO record
In forceUSPTO record
US 11,479,545Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction
In force
 · USPTO record
In forceUSPTO record
US 12,054,478Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction
In force
 · USPTO record
In forceUSPTO record
US 11,572,359PARP/PI3K double-target inhibit containing pyridopyrimidine structure
In force
 · USPTO record
In forceUSPTO record
US 11,504,385Proteolysis targeting chimeric molecule, preparation method, and application
In force
 · USPTO record
In forceUSPTO record
US 12,310,944Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof
In force
 · USPTO record
In forceUSPTO record
US 12,226,476Helper epitope peptide and application thereof
In force
 · USPTO record
In forceUSPTO record
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
Also on record, not counted in the 22: 6 patents in force now held by others · 14 lapsed for an unpaid fee · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

11 pending · 2 abandoned · 15 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited